Article
Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1
8 Jan 2020
Abstract excerpt
Infections due to carbapenem-resistant NDM-producing Escherichia coli represent a major therapeutic challenge, especially in situations of pre-existing colistin resistance. The aim of this study was to investigate combinatorial pharmacodynamics of colistin and tigecycline against E. coli harboring blaNDM-5 and mcr-1, with possible mechanisms explored as well. Colistin disrupted the bacterial outer-membrane and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
